Arthur Karnuah

Title: Arthur Karnuah: Innovator in Avian Nucleic Acid Technology

Introduction

Arthur Karnuah is an accomplished inventor based in Athens, GA (US). He has made significant contributions to the field of biotechnology, particularly in the area of avian nucleic acid molecules. His innovative work has implications for genetic engineering and transgenic research.

Latest Patents

Karnuah holds a patent for a groundbreaking invention titled "Chicken ovalbumin nucleotide sequence." This patent provides isolated and recombinant avian nucleic acid molecules that include at least one avian MAR and an avian nucleic acid sequence encoding an ovalbumin transcriptional regulatory region. The isolated nucleic acid is designed to reduce chromosomal positional effects on the transcription of a transgene linked to the ovalbumin transcriptional regulatory region. This invention is particularly useful for enhancing gene expression in transfected avian cells.

Career Highlights

Throughout his career, Karnuah has worked with notable organizations, including Synageva Biopharma Corporation and the University of Georgia Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Karnuah has collaborated with esteemed colleagues such as Markley C. Leavitt and Jeff Rapp. These partnerships have fostered a productive environment for innovation and research in avian biotechnology.

Conclusion

Arthur Karnuah's contributions to the field of avian nucleic acid technology exemplify the impact of innovative thinking in biotechnology. His patent on the chicken ovalbumin nucleotide sequence showcases his commitment to advancing genetic research and applications.